New Year Bumper Sale @ Rs. 1 X
Benelix BR 50/1.5/2.5 Syrup is a commercial drug that is prescribed in the form of Syrup. The alternative uses of Benelix BR 50/1.5/2.5 Syrup have also been explained below.
The right dosage of Benelix BR 50/1.5/2.5 Syrup depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Benelix BR 50/1.5/2.5 Syrup include Skin Rash, Epigastric Pain, Bronchospasm. While these are the most often observed Benelix BR 50/1.5/2.5 Syrup side effects, there are can be others also. These have been listed below. Usually, these side effects of Benelix BR 50/1.5/2.5 Syrup go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Benelix BR 50/1.5/2.5 Syrup has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Benelix BR 50/1.5/2.5 Syrup's effects on the liver, heart and kidney are discussed below in the Benelix BR 50/1.5/2.5 Syrup related warnings section.
Benelix BR 50/1.5/2.5 Syrup can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Benelix BR 50/1.5/2.5 Syrup in conditions like Asthma, Smoking Addiction. The section on Benelix BR 50/1.5/2.5 Syrup contraindications lists all such conditions.
Drug interactions for Benelix BR 50/1.5/2.5 Syrup have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Benelix BR 50/1.5/2.5 Syrup is not safe while driving, and is is not addictive in nature.
Benelix BR 50/1.5/2.5 Syrup is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Benelix BR 50/1.5/2.5 Syrup is used -
Moderate
Mild
Common
Is the use of Benelix BR 50/1.5/2.5 Syrup safe for pregnant women?
Benelix BR can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Benelix BR 50/1.5/2.5 Syrup safe during breastfeeding?
Benelix BR should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Benelix BR 50/1.5/2.5 Syrup on the Kidneys?
Kidney can be affected by Benelix BR. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Benelix BR 50/1.5/2.5 Syrup on the Liver?
Benelix BR is rarely harmful for the liver.
What is the effect of Benelix BR 50/1.5/2.5 Syrup on the Heart?
Benelix BR is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Benelix BR 50/1.5/2.5 Syrup unless your doctor advises you to do so -
Is this Benelix BR 50/1.5/2.5 Syrup habit forming or addictive?
Forming a habit of Benelix BR 50/1.5/2.5 Syrup has not been reported.
Interaction between Food and Benelix BR 50/1.5/2.5 Syrup
Due to the absence of research, it is difficult to say how Benelix BR 50/1.5/2.5 Syrup and food will interact.
Interaction between Alcohol and Benelix BR 50/1.5/2.5 Syrup
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Benelix BR 50/1.5/2.5 Syrup.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219